Kindora
FeaturesSocial Impact InvestmentsPricing
AboutLive Demos
Sign InSign Up
    Kindora
    FeaturesSocial Impact InvestmentsPricing
    AboutLive Demos
    Sign InSign Up
    1. Home
    2. Foundations
    3. John Martin Foundation
    John Martin Foundation logo

    John Martin Foundation

    ActivePhilanthropy & Voluntarism
    SAN FRANCISCO, CAWebsite4155616540EIN: 30-0948144

    About John Martin Foundation

    The John Martin Foundation concentrates on translational global health and biomedical research with an emphasis on improving access to treatments in low- and middle-income settings. Its major gifts fund drug development and disease-specific research (notably malaria, liver disease, and antimicrobials), health systems interventions that expand maternal and child care access, and policy work to accelerate access to medicines. Grants are large and programmatic, often targeted to applied research centers, implementation pilots, and licensing/policy initiatives that can enable broader uptake of medical innovations.

    Focus Areas

    Translational malaria drug development (single-dose cures and chemoprophylaxis)Non-alcoholic fatty liver disease (NAFLD) and liver research centersFintech-enabled maternal and child healthcare delivery in Africa (m-TIBA care bundles)Access to antimicrobials in low-resource settings via novel distribution/subscription modelsPolicy and voluntary licensing to accelerate access to essential medicines

    Who They Fund

    people living with hepatitis B and hepatitis Cmothers and newborns at risk of hepatitis B mother-to-child transmission

    About John Martin Foundation

    The John Martin Foundation’s recent giving is defined by large, programmatic investments in translational global health and biomedical research. One of its biggest commitments supports a $2.5 million center in West Bengal for liver research and innovations, showing how the foundation backs applied science alongside clinical capacity. Another major line of work funds malaria drug development, including a $2 million grant to The Scripps Research Institute for a single-dose cure and 28-day chemoprophylaxis to eradicate malaria. The foundation also supports access-to-medicine efforts, from antimicrobial subscription models to voluntary licensing and policy work aimed at lowering barriers to essential treatments. Across the portfolio, the John Martin Foundation combines research, implementation, and systems change. Its grants reach universities, hospitals, research foundations, and global health intermediaries, often for projects designed to move evidence into practice. In liver disease, the foundation has backed both center-building and disease-specific research, including NAFLD and hepatitis-related work. In infectious disease, it supports hepatitis B treatment scale-up, surveillance, and elimination networks, while also funding community-oriented programs in maternal and child health and underserved settings. The pattern is not small exploratory support; it is grantmaking at a scale that can underwrite centers, registries, pilot models, and field implementation.

    What John Martin Foundation Funds

    Liver disease is a consistent theme. The foundation gave $1.5 million to The Regents of the University of California San Diego for the UC San Diego Non-Alcoholic Fatty Liver Disease (NAFLD) Research Center, and $2.5 million to Liver Foundation West Bengal for the John C. Martin Centre for Liver Research and Innovations. It also funded hepatitis-related infrastructure and analysis, including work on hepatitis B transmission and treatment. In malaria, the foundation supported drug development directly through a $2 million grant to The Scripps Research Institute for MCMQ069 as a single-dose cure and 28-day chemoprophylaxis to eradicate malaria. Access to medicines is another clear thread: President and Fellows of Harvard College received $898,691 for work on voluntary licensing and a path to accelerate access to medicines, while Health Innovation and Investment Exchange received $65,000 for identifying opportunities and challenges in voluntary licensing in Southeast Asia. The portfolio also includes health system and community delivery projects, such as financing and mobile technology in Kenya and maternal and child healthcare through m-TIBA care bundles.

    Financial Snapshot

    Annual Giving

    $11.2M

    Total Assets

    $52.4M

    Total Revenue

    $1.6M

    Total Expenses

    $9.6M

    Typical Grant Size

    Most grants fall between $100K and $1M, with a median of $300K.

    25th Percentile

    $100K

    Median

    $300K

    75th Percentile

    $1M

    Geographic Reach

    National5 states funded

    About 29% of grants go to recipients in GA.

    Funding intensity
    Low
    High
    Headquarters
    Funding intensity
    Low
    High

    Where John Martin Foundation Funds

    Top 8 recipient countries by grant volume for John Martin Foundation.

    RankCountryGrantsTotalShare
    1United StatesDomestic20$16.2M
    38.5%
    2Netherlands7$9.8M

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    Explore related grant guides

    Grants in California

    Want a Personalized Pitch for John Martin Foundation?

    Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.

    Get Started FreeView Pricing
    Free plan available
    No contracts
    Cancel anytime
    Free Weekly Newsletter

    The Grant Brief

    Weekly grant intelligence for social impact leaders. Curated opportunities, funding trends, and strategic insights — free.

    Join 500+ social impact leaders. Unsubscribe anytime. Privacy Policy

    Trusted by mission-driven teams at organizations nationwide

    Kindora Logo

    At Kindora, we combine data-driven insights with a human touch to create meaningful, strategic fundraising solutions for mission-driven organizations of all sizes.

    Get The Grant Brief — free weekly grant intelligence

    Quick Links

    • Features
    • Social Impact Investments
    • About Us
    • Mission
    • How It Works
    • Pricing
    • Sales deck
    • Philanthropy Jobs
    • Nonprofit Compensation
    • Live demo (every plan)
    • Individual prospecting demoBeta
    • Blog
    • FAQ
    • Getting Started

    Connect With Us

    LinkedInTwitterFacebook

    Find Grants

    Grants by CauseGrants by StateFoundations by CityEducation GrantsHealth GrantsArts & Culture GrantsEnvironment GrantsCommunity Development GrantsYouth Development Grants

    © 2026 Kindora. All rights reserved.

    Privacy PolicyTerms of ServiceSystem Status
    2 filings on record
    See If You're a Fit — FreeFree account · instant fit score · similar funders
    rural and underserved communities (Pakistan, Uganda, Ethiopia, China)
    garment factory and textile mill workers (Bangladesh)
    transgender women (PrEP interventions, India)
    health systems / policymakers in LMICs (Kenya, Botswana, Southeast Asia)
    clinical researchers and early-career scientists (scholarships, fellowships)

    Giving Approach

    Concentrated, high-value grants (several multi-million-dollar awards) to a small number of strategic partners; a mix of repeat funding to research institutions and one-off large grants for implementation pilots and policy work across global sites.

    Funding Style

    capacity building (research infrastructure & training)implementation / pilot programshealth systems strengtheningresearch & development (clinical & translational)knowledge dissemination & convening (conferences, lectures, podcasts)

    Notable grantees: The Scripps Research Institute, PharmAccess Foundation, Liver Foundation West Bengal, University of California San Diego (Regents), ArandaOrg Inc

    Topics

    hepatitis B elimination and prevention (including PMTCT)hepatitis C diagnosis and treatment scale-upliver disease research (NAFLD, cirrhosis)access to medicines and voluntary licensing / market-shaping for antimicrobialsantimicrobial resistance surveillance and stewardshipmalaria single-dose cure and chemoprophylaxis developmentuniversal health coverage / social health insurance and maternal & child health quality

    How John Martin Foundation Gives

    The John Martin Foundation’s typical grant size is $100,000 at the 25th percentile, $300,000 at the median, and $1,000,000 at the 75th percentile, indicating a portfolio built around sizeable program grants. The same organizations appear across multiple years in several cases, including PharmAccess Foundation, Integral Global Consulting, The Scripps Research Institute, and Vestfold Hospital, which suggests recurring support for selected initiatives rather than one-time awards. The foundation is classified as a regular funder, not a DAF or program-related investment vehicle. Unsolicited applications are not indicated in the provided program descriptions, and several active programs explicitly note that they do not accept unsolicited requests.

    Where John Martin Foundation Makes Grants

    Grant recipients are spread nationally, with the highest concentration in Georgia by grant count. The HQ state, California, accounts for 29% of grants to recipients in the recent dataset, but the giving footprint extends well beyond it. Recent grants reached cities including La Jolla, New York, Atlanta, Cambridge, Lahore, Islamabad, Geneva, Vancouver, Buenos Aires, and West Bengal. Outside the United States, the recipient-country distribution includes Norway, the Netherlands, Eswatini, India, Argentina, Canada, and Switzerland.

    Frequently Asked Questions About John Martin Foundation

    What kinds of work does The John Martin Foundation support most often?

    Its recent grants focus on translational global health and biomedical research, especially malaria drug development, liver disease and hepatitis programs, access to medicines, and health system interventions. Examples in the dataset include malaria cure development, NAFLD research, hepatitis B treatment scale-up, and voluntary licensing work to improve access to medicines.

    What is the foundation’s typical grant size?

    The typical grant size is $100,000 at the 25th percentile, $300,000 at the median, and $1,000,000 at the 75th percentile. That distribution shows that many awards are substantial program grants rather than small project checks.

    Does the foundation fund the same organizations in more than one year?

    Yes. Several recipients appear across multiple years in the recent grant list, including PharmAccess Foundation, Integral Global Consulting, The Scripps Research Institute, and Vestfold Hospital. That pattern points to repeated support for ongoing projects and programs.

    Where do most grants go geographically?

    The top state by grant count is Georgia. California is the HQ state and receives 29% of grants to recipients in the dataset, while recipients also appear in cities such as La Jolla, New York, Atlanta, Cambridge, Geneva, Vancouver, Buenos Aires, and West Bengal.

    What access-to-medicines work has the foundation funded?

    It has supported voluntary licensing and pharmaceutical access policy, including a $898,691 grant to President and Fellows of Harvard College for work on voluntary licensing and a $65,000 grant to Health Innovation and Investment Exchange for analysis of voluntary licensing opportunities and challenges in Southeast Asia.

    Latest 990 Filing

    2024

    Source: IRS Form 990-PF, fiscal year 2024.

    13.5%
    3Norway7$1.8M
    13.5%
    4Switzerland6$1.3M
    11.5%
    5India4$5.2M
    7.7%
    6Argentina4$258K
    7.7%
    7China2$500K
    3.9%
    8Canada2$300K
    3.9%

    Recipient country reflects the grantee's headquarters per IRS 990-PF and Schedule F filings, not the program's implementation country.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    THE SCRIPPS RESEARCH INSTITUTELA JOLLA, CA$2,000,0002024MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA
    ARANDAORG INCNEW YORK, NY$2,000,0002024PILOTING THE ARANDA SUBSCRIPTION MODEL FOR ACCESS TO ANTIMICROBIALS IN BOTSWANA
    THE SCRIPPS RESEARCH INSTITUTELA JOLLA, CA$2,000,0002024MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA
    PHARM ACCESS FOUNDATIONAMSTERDAM$1,000,0002024IMPROVE QUALITY OF MATERNAL AND CHILDCARE THROUGH M-TIBA CARE BUNDLES
    PHARM ACCESS FOUNDATIONAMSTERDAM$1,000,0002024THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS A KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH
    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLA JOLLA, CA$1,000,0002024UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER
    INTEGRAL GLOBAL CONSULTINGNE ATLANTA, GA$500,0002024LINKAGE TO CARE AND HEALTH EDUCATION IN UNDERSERVED COMMUNITIES OF ISLAMABAD, PAKISTAN
    INTEGRAL GLOBAL CONSULTINGNE ATLANTA, GA$300,0002024MITIGATION THE SPREAD OF COVID-19 AMONG GARMENT FACTORY AND TEXTILE MILL POPULATIONS IN BANGLADESH: PHASE II TRANSLATING RESULTS INTO SUSTAINED SECTOR PRACTICE
    KING BAUDOUIN FOUNDATION UNITED STATES INCNEW YORK, NY$300,0002024THE GLOBAL HEALTH DIPLOMATS PODCAST: PROPOSAL TO HONOR THE MEMORY OF JOHN C. MARTIN
    VESTFOLD HOSPITALTONSBERG$270,2402024HEPATITIS B IN SUB-SAHARAN AFRICA: SCALING UP TREATMENT IN ETHIOPIA
    VESTFOLD HOSPITALTONSBERG$230,0002024HEPSANET: A COLLABORATIVE HEPATITIS B REGISTRY IN AFRICA
    WORLD HEPATITIS ALLIANCEGENEVA$150,0002024COMMUNITY IMPACT PROGRAMME
    TASK FORCE FOR GLOBAL HEALTH COALITION FOR GLOBAL HEPATITIS ELIMINATION (CGDECATUR, GA$150,0002024UN GROUP OF FRIENDS TO ELIMINATE HEPATITIS
    MCI GROUP CANADAVANCOUVER$150,000202418TH INTERNATIONAL SYMPOSIUM OF VIRAL HEPATITIS & LIVER DISEASES (ISVHLD) GLOBAL HEPATITIS SUMMIT 2023
    HEALTH INNOVATION AND INVESTMENT EXCHANGE (HIEX)GENEVA$65,0002024TOWARDS ACCESS TO MEDICINE IN THE SOUTHEAST ASIA REGION IDENTIFYING POTENTIAL OPPORTUNITIES AND CHALLENGES IN IMPLEMENTING VOLUNTARY LICENSING FOR ACCESS TO MEDICINE (VLAM) IN THE SOUTHEAST ASIA REGION
    ICALMABUENOS AIRES$50,8802024ANTIMICROBIAL RESISTANCE PATTERNS OF BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS: A SURVEILLANCE PROJECT FROM ARGENTINA AND URUGUAY
    THE SCRIPPS RESEARCH INSTITUTELA JOLLA, CA$50,0002024ENDOWMENT FOR AN ANNUAL LECTURE SERIES IN MEMORY OF CHRISTOPHER WALSH
    LIVER FOUNDATION WEST BENGALWEST BENGAL$2,500,0002023JOHN C. MARTIN CENTRE FOR LIVER RESEARCH AND INNOVATIONS
    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLA JOLLA, CA$1,500,0002023UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER
    PHARM ACCESS FOUNDATIONAMSTERDAM$1,257,9972023THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH
    PRESIDENT AND FELLOWS OF HARVARD COLLEGECAMBRIDGE, MA$898,6912023MAKING THE CASE FOR VOLUNTARY LICENSING - CRAFTING A PATH FORWARD A ACCELERATE ACCESS TO MEDICINES
    NEW DISCOVERY LLCFLUSHING, NY$476,4962023TENOFOVIR IN COMBINATION OF HEPATITIS B VACCINE WITH THE OMISSION OF IMMUNE GLOBULIN TO PREVENT HEPATITIS B TRANSMISSION IN MOTHERS WITH HIGH VIRAL LOAD
    CENTER FOR DISEASE ANALYSIS FOUNDATIONLAFAYETTE, CO$410,5202023REDUCTION OF HEPATITIS B VIRUS MOTHER TO CHILD TRANSMISSION IN UGANDA
    VESTFOLD HOSPITALTONSBERG$300,0002023HEPATITIS B IN SUB-SAHARA AFRICA: SCALING UP TREATMENT IN ETHIOPIA
    INTEGRAL GLOBAL CONSULTINGNE ATLANTA, GA$300,0002023MITIGATION THE SPREAD OF COVID-19 AMONG GARMENT FACTORY AND TEXTILE MILL POPULATIONS IN BANGLADESH: PHASE II TRANSLATING RESULTS INTO SUSTAINED SECTOR PRACTICE
    VESTFOLD HOSPITALTONSBERG$100,0002023HEPATITIS B IN SUB-SAHARA AFRICA COLLABORATIVE NETWORK (HEPSANET)
    YR GAITONDE MEDICAL EDUCATIONAL AND RESEARCH FOUNDATIONCHENNAI$100,0002023PRE-RISK EXPOSURE (PREP) FOR TRANSWOMEN IN INDIA
    ICALMA FOUNDATIONBUENOS AIRES$77,8802023PROJECT ECHO-LIVER HEALTH
    INTEGRAL GLOBAL CONSULTINGNE ATLANTA, GA$39,8422023INCREASING ACCESS TO DIAGNOSIS AND TREATMENT OF HEPATITIS C IN A RURAL UNDERSERVED COMMUNITY OF ISLAMABAD- AN ACTION MODEL FROM PAKISTAN'S NATIONAL HEPATITIS STRATEGIC FRAMEWORK
    CENTER FOR DISEASE ANALYSIS FOUNDATIONLAFAYETTE, CO$38,5002023ANALYSIS: ESTIMATING THE NUMBER OF TREATED HEPATITIS B & C PATIENTS IN CHINA
    INFORMED HORIZONS EDUCATIONTUCKER, GA$15,0002023YOUNG SCIENTIST SCHOLARSHIPS PROGRAM

    THE SCRIPPS RESEARCH INSTITUTE

    $2,000,000
    LA JOLLA, CA2024

    MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA

    ARANDAORG INC

    $2,000,000
    NEW YORK, NY2024

    PILOTING THE ARANDA SUBSCRIPTION MODEL FOR ACCESS TO ANTIMICROBIALS IN BOTSWANA

    THE SCRIPPS RESEARCH INSTITUTE

    $2,000,000
    LA JOLLA, CA2024

    MCMQ069 AS A SINGLE-DOSE CURE AND 28-DAY CHEMOPROPHYLAXIS TO ERADICATE MALARIA

    PHARM ACCESS FOUNDATION

    $1,000,000
    AMSTERDAM2024

    IMPROVE QUALITY OF MATERNAL AND CHILDCARE THROUGH M-TIBA CARE BUNDLES

    PHARM ACCESS FOUNDATION

    $1,000,000
    AMSTERDAM2024

    THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS A KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO

    $1,000,000
    LA JOLLA, CA2024

    UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER

    INTEGRAL GLOBAL CONSULTING

    $500,000
    NE ATLANTA, GA2024

    LINKAGE TO CARE AND HEALTH EDUCATION IN UNDERSERVED COMMUNITIES OF ISLAMABAD, PAKISTAN

    INTEGRAL GLOBAL CONSULTING

    $300,000
    NE ATLANTA, GA2024

    MITIGATION THE SPREAD OF COVID-19 AMONG GARMENT FACTORY AND TEXTILE MILL POPULATIONS IN BANGLADESH: PHASE II TRANSLATING RESULTS INTO SUSTAINED SECTOR PRACTICE

    KING BAUDOUIN FOUNDATION UNITED STATES INC

    $300,000
    NEW YORK, NY2024

    THE GLOBAL HEALTH DIPLOMATS PODCAST: PROPOSAL TO HONOR THE MEMORY OF JOHN C. MARTIN

    VESTFOLD HOSPITAL

    $270,240
    TONSBERG2024

    HEPATITIS B IN SUB-SAHARAN AFRICA: SCALING UP TREATMENT IN ETHIOPIA

    VESTFOLD HOSPITAL

    $230,000
    TONSBERG2024

    HEPSANET: A COLLABORATIVE HEPATITIS B REGISTRY IN AFRICA

    WORLD HEPATITIS ALLIANCE

    $150,000
    GENEVA2024

    COMMUNITY IMPACT PROGRAMME

    TASK FORCE FOR GLOBAL HEALTH COALITION FOR GLOBAL HEPATITIS ELIMINATION (CG

    $150,000
    DECATUR, GA2024

    UN GROUP OF FRIENDS TO ELIMINATE HEPATITIS

    MCI GROUP CANADA

    $150,000
    VANCOUVER2024

    18TH INTERNATIONAL SYMPOSIUM OF VIRAL HEPATITIS & LIVER DISEASES (ISVHLD) GLOBAL HEPATITIS SUMMIT 2023

    HEALTH INNOVATION AND INVESTMENT EXCHANGE (HIEX)

    $65,000
    GENEVA2024

    TOWARDS ACCESS TO MEDICINE IN THE SOUTHEAST ASIA REGION IDENTIFYING POTENTIAL OPPORTUNITIES AND CHALLENGES IN IMPLEMENTING VOLUNTARY LICENSING FOR ACCESS TO MEDICINE (VLAM) IN THE SOUTHEAST ASIA REGION

    ICALMA

    $50,880
    BUENOS AIRES2024

    ANTIMICROBIAL RESISTANCE PATTERNS OF BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS: A SURVEILLANCE PROJECT FROM ARGENTINA AND URUGUAY

    THE SCRIPPS RESEARCH INSTITUTE

    $50,000
    LA JOLLA, CA2024

    ENDOWMENT FOR AN ANNUAL LECTURE SERIES IN MEMORY OF CHRISTOPHER WALSH

    LIVER FOUNDATION WEST BENGAL

    $2,500,000
    WEST BENGAL2023

    JOHN C. MARTIN CENTRE FOR LIVER RESEARCH AND INNOVATIONS

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO

    $1,500,000
    LA JOLLA, CA2023

    UC SAN DIEGO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) RESEARCH CENTER

    PHARM ACCESS FOUNDATION

    $1,257,997
    AMSTERDAM2023

    THE JOURNEY TOWARDS UHC: KISUMU COUNTY AS KENYAN MODEL FOR SOCIAL HEALTH INSURANCE AND BETTER HEALTH

    PRESIDENT AND FELLOWS OF HARVARD COLLEGE

    $898,691
    CAMBRIDGE, MA2023

    MAKING THE CASE FOR VOLUNTARY LICENSING - CRAFTING A PATH FORWARD A ACCELERATE ACCESS TO MEDICINES

    NEW DISCOVERY LLC

    $476,496
    FLUSHING, NY2023

    TENOFOVIR IN COMBINATION OF HEPATITIS B VACCINE WITH THE OMISSION OF IMMUNE GLOBULIN TO PREVENT HEPATITIS B TRANSMISSION IN MOTHERS WITH HIGH VIRAL LOAD

    CENTER FOR DISEASE ANALYSIS FOUNDATION

    $410,520
    LAFAYETTE, CO2023

    REDUCTION OF HEPATITIS B VIRUS MOTHER TO CHILD TRANSMISSION IN UGANDA

    VESTFOLD HOSPITAL

    $300,000
    TONSBERG2023

    HEPATITIS B IN SUB-SAHARA AFRICA: SCALING UP TREATMENT IN ETHIOPIA

    INTEGRAL GLOBAL CONSULTING

    $300,000
    NE ATLANTA, GA2023

    MITIGATION THE SPREAD OF COVID-19 AMONG GARMENT FACTORY AND TEXTILE MILL POPULATIONS IN BANGLADESH: PHASE II TRANSLATING RESULTS INTO SUSTAINED SECTOR PRACTICE

    VESTFOLD HOSPITAL

    $100,000
    TONSBERG2023

    HEPATITIS B IN SUB-SAHARA AFRICA COLLABORATIVE NETWORK (HEPSANET)

    YR GAITONDE MEDICAL EDUCATIONAL AND RESEARCH FOUNDATION

    $100,000
    CHENNAI2023

    PRE-RISK EXPOSURE (PREP) FOR TRANSWOMEN IN INDIA

    ICALMA FOUNDATION

    $77,880
    BUENOS AIRES2023

    PROJECT ECHO-LIVER HEALTH

    INTEGRAL GLOBAL CONSULTING

    $39,842
    NE ATLANTA, GA2023

    INCREASING ACCESS TO DIAGNOSIS AND TREATMENT OF HEPATITIS C IN A RURAL UNDERSERVED COMMUNITY OF ISLAMABAD- AN ACTION MODEL FROM PAKISTAN'S NATIONAL HEPATITIS STRATEGIC FRAMEWORK

    CENTER FOR DISEASE ANALYSIS FOUNDATION

    $38,500
    LAFAYETTE, CO2023

    ANALYSIS: ESTIMATING THE NUMBER OF TREATED HEPATITIS B & C PATIENTS IN CHINA

    INFORMED HORIZONS EDUCATION

    $15,000
    TUCKER, GA2023

    YOUNG SCIENTIST SCHOLARSHIPS PROGRAM